Brainstorm Cell Therapeutics reported $184K in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Biogen USD 9.19B 216.3M Mar/2026
Brainstorm Cell Therapeutics USD 184K 123K Mar/2026
Cipla INR 241.47B 7.71B Mar/2026
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 148.02M 59.1M Dec/2025
CSL USD 11.85B 1000K Dec/2025
Cytokinetics USD 839.46M 77.51M Mar/2026
Gilead Sciences USD 18.64B 1.25B Mar/2026
Grifols EUR 5.96B 316.31M Dec/2025
Halozyme Therapeutics USD 1B 177.83M Mar/2026
Mesoblast USD 202.48M 1.87M Dec/2025